These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35034099)
1. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Ciampa CJ; Parent JH; Harrison TM; Fain RM; Betts MJ; Maass A; Winer JR; Baker SL; Janabi M; Furman DJ; D'Esposito M; Jagust WJ; Berry AS Neuropsychopharmacology; 2022 Apr; 47(5):1106-1113. PubMed ID: 35034099 [TBL] [Abstract][Full Text] [Related]
2. Pathological and neurochemical correlates of locus coeruleus functional network activity. Parent JH; Cassady K; Jagust WJ; Berry AS Biol Psychol; 2024 Oct; 192():108847. PubMed ID: 39038634 [TBL] [Abstract][Full Text] [Related]
3. Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging. Parent JH; Ciampa CJ; Harrison TM; Adams JN; Zhuang K; Betts MJ; Maass A; Winer JR; Jagust WJ; Berry AS Neuroimage; 2022 Nov; 263():119658. PubMed ID: 36191755 [TBL] [Abstract][Full Text] [Related]
4. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study. Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798 [TBL] [Abstract][Full Text] [Related]
5. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer's disease. Cassidy CM; Therriault J; Pascoal TA; Cheung V; Savard M; Tuominen L; Chamoun M; McCall A; Celebi S; Lussier F; Massarweh G; Soucy JP; Weinshenker D; Tardif C; Ismail Z; Gauthier S; Rosa-Neto P Neuropsychopharmacology; 2022 Apr; 47(5):1128-1136. PubMed ID: 35177805 [TBL] [Abstract][Full Text] [Related]
6. Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease. Prokopiou PC; Engels-Domínguez N; Schultz AP; Sepulcre J; Koops EA; Papp KV; Marshall GA; Normandin MD; El Fakhri G; Rentz D; Sperling RA; Johnson KA; Jacobs HIL Neurology; 2023 Sep; 101(12):e1206-e1217. PubMed ID: 37491329 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's pathology targets distinct memory networks in the ageing brain. Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481 [TBL] [Abstract][Full Text] [Related]
8. Poorer aging trajectories are associated with elevated serotonin synthesis capacity. Markova TZ; Ciampa CJ; Parent JH; LaPoint MR; D'Esposito M; Jagust WJ; Berry AS Mol Psychiatry; 2023 Oct; 28(10):4390-4398. PubMed ID: 37460847 [TBL] [Abstract][Full Text] [Related]
9. Subthreshold Amyloid Predicts Tau Deposition in Aging. Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045 [TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease. Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ; Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897 [TBL] [Abstract][Full Text] [Related]
15. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging. Satoh A; Iijima KM Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876 [TBL] [Abstract][Full Text] [Related]
16. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity. Huijbers W; Schultz AP; Papp KV; LaPoint MR; Hanseeuw B; Chhatwal JP; Hedden T; Johnson KA; Sperling RA J Neurosci; 2019 Jan; 39(3):548-556. PubMed ID: 30482786 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment. Mimmack KJ; Sprague EH; Amariglio RE; Vannini P; Marshall GA J Prev Alzheimers Dis; 2024; 11(4):966-974. PubMed ID: 39044507 [TBL] [Abstract][Full Text] [Related]
18. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults. Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559 [TBL] [Abstract][Full Text] [Related]
19. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
20. Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe. Adams JN; Maass A; Berron D; Harrison TM; Baker SL; Thomas WP; Stanfill M; Jagust WJ J Neurosci; 2021 Apr; 41(17):3917-3931. PubMed ID: 33731446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]